Chemcrux Enterprises Ltd (CHEMCRUX) — shareholding pattern, promoter holding, financials and share price
About Chemcrux Enterprises Ltd (CHEMCRUX)
Chemcrux Enterprises Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as CHEMCRUX and on the BSE under scrip code 540395. Its ISIN is INE298W01016.
Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates [1]
Chemcrux Enterprises Limited primarily manufactures intermediates for bulk drugs, dyes, and pigments using specialized chemical processes like high-pressure oxidation and chlorosulfonation.
The company has established a robust clientele comprising both multinational corporations and leading pharmaceutical organizations in India and has a consistent export presence in multiple countries.
Listed peers in Specialty Chemicals: IVP Ltd, Jaysynth Orgochem Ltd, Resonance Specialities Ltd, Ishan Dyes and chemicals Ltd, Polson Ltd, Biopol Chemicals Ltd.
Valuation & Returns
10 Jul 2026At ₹89 a share on 10 Jul 2026, Chemcrux Enterprises Ltd (CHEMCRUX) was valued at a price-to-earnings ratio of 35.33x against an industry P/E of 45.11x and a price-to-book of 1.77x on a book value of ₹50.39 per share as of Mar 2025. Solomo computes return on equity of 5% and return on capital employed of 7.22% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 35.33x
- Industry P/E
- 45.11x
- P/B
- 1.77x
- EPS (TTM)
- ₹2.52
- Book value / share
- ₹50.39
- ROE
- 5%
- ROCE
- 7.22%
- ROA
- 2.94%
- Debt / equity
- 0.57x
- Dividend yield
- 1.12%
- EBITDA margin
- 16.33%
- 52-week range
- ₹64 – ₹158.6
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Chemcrux Enterprises Ltd (CHEMCRUX) reported revenue of ₹80.65 crore, net profit of ₹3.73 crore and earnings per share of ₹2.52. That compares with revenue of ₹70.01 crore and net profit of ₹3.91 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹24.28 crore and net profit ₹1.85 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 95.27 | 95.15 | 78.47 | 70.01 | 80.65 |
| Net profit (₹ cr) | 14.86 | 14.36 | 8.44 | 3.91 | 3.73 |
| EPS (₹) | 10.03 | 9.7 | 5.7 | 2.64 | 2.52 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 14.18% | 4.11% | -9.66% | -10.78% |
| Profit growth | 10.26% | -17.01% | -34.43% | -53.67% |
| Stock price CAGR | - | -2% | -34% | -30% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 72.92% of Chemcrux Enterprises Ltd (CHEMCRUX) (unchanged from the previous quarter). Market capitalisation was ₹132 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2017.
Largest disclosed public shareholders in Jun 2026: PRASENJIT KUMAR PAUL 1.48%, NAMITA BHANDARE 1.01%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 72.92% | - | - | - | 27.08% |
| Mar 2026 | 72.92% | - | - | - | 27.08% |
| Dec 2025 | 72.92% | - | - | - | 27.08% |
| Sep 2025 | 72.92% | - | - | - | 27.08% |
| Jun 2025 | 72.92% | - | - | - | 27.08% |
| Mar 2025 | 72.92% | - | - | - | 27.08% |
| Dec 2024 | 72.92% | - | - | - | 27.08% |
| Sep 2024 | 72.92% | - | - | - | 27.08% |